Cyramza Drug Interactions
Currently displaying a list of 142 drugs known to interact with Cyramza (ramucirumab).
- 100 major drug interactions
- 42 moderate drug interactions
Medications known to interact with Cyramza
Note: Showing generic names only.
- abciximab
- acalabrutinib
- ado-trastuzumab emtansine
- alteplase
- anagrelide
- anisindione
- anistreplase
- antithrombin (recombinant)
- antithrombin iii
- apixaban
- ardeparin
- argatroban
- aspirin
- avapritinib
- cabozantinib
- cangrelor
- caplacizumab
- choline salicylate
- cilostazol
- citalopram
- clomipramine
- clopidogrel
- dabigatran
- dalteparin
- danaparoid
- daprodustat
- dasatinib
- deferasirox
- defibrotide
- deoxycholic acid
- desirudin
- desvenlafaxine
- dexfenfluramine
- dextran 1
- dextran, high molecular weight
- dextran, low molecular weight
- diclofenac
- diclofenac ophthalmic
- diclofenac topical
- dicumarol
- diflunisal
- dimethyl fumarate
- dipyridamole
- diroximel fumarate
- drotrecogin alfa
- duloxetine
- edoxaban
- efgartigimod alfa
- encorafenib
- enoxaparin
- epoprostenol
- eptifibatide
- erlotinib
- escitalopram
- etodolac
- fedratinib
- fenfluramine
- fenoprofen
- fluoxetine
- flurbiprofen
- flurbiprofen ophthalmic
- fluvoxamine
- fondaparinux
- panobinostat
- paroxetine
- pentosan polysulfate sodium
- phenylbutazone
- piroxicam
- plicamycin
- ponatinib
- prasugrel
- salsalate
- sertraline
- sibutramine
- sodium salicylate
- sodium thiosalicylate
- streptokinase
- sulfinpyrazone
- sulindac
- suprofen ophthalmic
- tazemetostat
- tenecteplase
- ticagrelor
- ticlopidine
- tinzaparin
- tipranavir
- tirofiban
- tolmetin
- tositumomab
- tovorafenib
- treprostinil
Cyramza disease interactions
There are 8 disease interactions with Cyramza (ramucirumab) which include:
- bleeding
- GI perforation
- hypothyroidism
- liver dysfunction
- hypertension
- PRES
- proteinuria
- thromboembolic disorders
More about Cyramza (ramucirumab)
- Cyramza consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: VEGF/VEGFR inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Opdivo Qvantig
Opdivo Qvantig is used to treat adults with melanoma, non-small cell lung cancer, renal cell ...
Rybrevant
Rybrevant is used to treat certain types of non-small cell lung cancer (NSCLC) in adults. It is ...
Enhertu
Enhertu is a treatment for breast cancer, stomach cancer, and non-small cell lung cancer with HER2 ...
Opdivo
Opdivo is used to treat many cancers, such as melanoma, non-small cell lung cancer, malignant ...
Keytruda
Keytruda is used to treat multiple types of cancer such as melanoma, non-small cell lung cancer ...
Avastin
Avastin is used to brain tumors and cancers of the kidney, colon, rectum, or lung. Learn about side ...
Paclitaxel
Paclitaxel systemic is used for breast cancer, breast cancer, adjuvant, breast cancer, metastatic ...
Trastuzumab
Trastuzumab systemic is used for breast cancer, breast cancer, adjuvant, breast cancer, metastatic ...
Cisplatin
Cisplatin systemic is used for anal cancer, bladder cancer, blood cell transplantation, bone marrow ...
Fluorouracil
Fluorouracil systemic is used for anal cancer, breast cancer, breast cancer, palliative, cancer ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.